Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU944
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,947
Award facts
- Contract value 100% obligated
- $32,946.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,946.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on December 22, 2025, with a completion date of December 23, 2025. The award was made without a set-aside designation, indicating competitive selection among eligible vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order was issued under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp's substantial IDC with the Defense Logistics Agency enables the company to supply a wide range of pharmaceutical products and medical commodities to support Department of Defense healthcare programs. The company's federal contracting portfolio demonstrates extensive experience fulfilling pharmaceutical needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This particular delivery order for Zepbound, a GLP-1 receptor agonist used for weight management, reflects the company's role as a critical vendor in the federal medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FU944?
SPE2DR26FU944 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FU944 worth?
The government has obligated $32,947 on SPE2DR26FU944.
Is contract SPE2DR26FU944 an order under another contract?
Yes. SPE2DR26FU944 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU944 competed?
The extent of competition for SPE2DR26FU944 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award